ArticleFrontiers in immunology2018

Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells.

Kristin M Snyder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.